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Intracellular trafﬁckingThe growing number of reports on the effective cargo delivery by cell-penetrating peptides (CPPs) has
extensively widened our knowledge about the mechanisms involved in CPP-mediated delivery. However,
the data available on the internalization mode of CPP–cargo complexes are often conﬂicting and/or
equivocal. Moreover, the intracellular trafﬁcking of CPP–cargo complexes is, to date, relatively unexplored
resulting in only minimal information about what is really happening to the complexes inside the cell. This
review focuses on deﬁning the endocytic pathways engaged in the transduction of CPP–cargo complexes and
seeks to determine the extent of different endocytic routes required for effective uptake. In addition, the
intracellular pathways utilized during the trafﬁcking and sorting of CPP–cargo complexes as well as the
ultimate fate of the complexes inside cells will be discussed., Estonia. Tel.: +3727375049;
this review.
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Cell-penetrating peptides (CPP) as alternative vehicles for the
intracellular delivery of compounds of interest have found both
recognition and wide application in molecular biotechnology. A large
number of CPPs induce the cellular uptake of bioactive molecules of
different size and nature, insisting on the ﬁrst clinical applications of
CPPs to emerge in the near future. In addition, the intracellular targets
that have become reachable by overcoming the plasma membrane
barrier might open new horizons in therapeutic strategies. Thenumerous in vitro and in vivo studies that demonstrate the high
biological activity of the cargo inserted into cells by CPPs, whereas the
vector peptide does not exert toxic effects [1–4], corroborate the high
potential of CPPs as carriers for therapeutics.
However, despite the clear advantages of CPP-mediated delivery,
two questions have to be answered before their wide application in
vivo. First, to predict and avoid unwanted side effects, a detailed
knowledge about the mode of cellular uptake and the intracellular
fate of the delivered active molecules is needed. CPPs are reported to
transduce cargoes into cells using endosomal pathways, but for some
peptides and small cargoes, a nonendosomal internalization mode,
depending on the peptide concentration [5–8] and/or the properties
of the cargo molecule [9], has also been indicated. However, the
endosomal route prevails in the uptake of bigger cargoes such as
proteins [10–13], liposomes [14], and nanoparticles [15]. On one hand,
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makes use of a naturally occurring cellular transport process. Yet, on
the other, the entrapment of the bioactive load in endosomal vesicles
usually leads to its degradation in the lysosomes, and if the target of
the delivered cargo is outside of the endosomal pathway, the efﬁcient
uptake does not result in a wanted biological activity. Still, in several
studies, the seemingly endocytically internalized cargo was functional
on targets outside of the endosomes, meaning that under favorable
conditions (i.e., requisite pH and/or intravesicular concentration of
CPP–cargo complexes, etc.) the cargo might escape from the
endosomes and retain its biological activity [10,16]. The poor
understanding of this process is the second big hindrance in the
application of CPPs in vivo because the extent of the endosomal
escape induced by the physicochemical properties of the peptides is
not yet known. The conditions that trigger the escape of a CPP from
the endosomes can be created by the endosomal maturation and/or
the accompanying pH decrease, a strategy utilized by proteins of
several pathogens to translocate from the endosome to the cytosol
[17,18]. Nevertheless, evidence that the hindrance of endosomal
acidiﬁcation increases the biological activity of the cargo molecule
delivered into cells by CPPs [16] argues against the general
requirement for the pH drop in this process. In this review, the
exploitation of different endosomal pathways in the protein cellular
delivery by CPPs and the intracellular trafﬁcking of CPP–cargo
complexes will be discussed.
2. From the plasma membrane to the cell interior
Two major cell entry routes contribute to the cytosolic transloca-
tion of CPP–cargo complexes: the direct cell membrane penetration
and the endosomal pathway, requiring ﬁrst the endocytic entry
followed by endosomal escape. The occurrence of direct passage
through the plasma membrane is a hotly disputed topic, yet its
relevance in CPP uptake is more commonly established when CPPs
alone are used [19–21] rather than for CPP–cargo complexes. Still,
some reports suggest that, for example, Pep-1 family peptides (also
called Chariot peptides) can facilitate the uptake of a cargo molecule
into the cell also via a nonendocytic mechanism by forming a helical
structure upon interaction with the plasma membrane lipids and
inserting into the lipid bilayer [22,23]. On the contrary, Petrescu et al.
[24] have demonstrated that Pep-1 can increase the uptake of a cargo
protein and indeed enhance its escape from the endocytic vesicles, yet
the uptake mechanism of the peptide–protein complex on the plasma
membrane follows the typical endocytic routes—macropinocytosis
and clathrin-mediated endocytosis. It is therefore possible that some
CPPs may promote the internalization of the cargo molecule through
direct penetration across the plasma membrane; still, the majority of
CPPs attached to a cargo molecule (i.e., protein, oligonucleotide, etc.)
utilize the endocytic machinery to gain entry to cells [25–30].
3. Enhancement of direct penetration by counteranion interaction
The direct passage through the plasma membrane to the cytosol
makes the bioactive cargo molecule easily accessible for interaction
with its target molecule(s) or, if necessary, for further targeting to the
requisite intracellular compartment(s). Thus, the improvement of the
process of direct penetration of CPP–cargo complexes across the
membrane barrier would signiﬁcantly enhance the desired biological
effects of the cargo molecule.
A few years ago, Takeuchi et al. [31] demonstrated that the
cytosolic delivery of protein cargo into cells using arginine-rich
peptides, especially oligoarginines, can be substantially increased by
negatively charged counteranions with high hydrophobicity, such as
pyrenebutyrate. The counteranion pyrenebutyrate is reported to
insert into lipid bilayers via its hydrophobic moiety and, through
the electrostatic bidentate hydrogen bonding, interact with thearginine residues during CPP treatment, inducing a direct penetration
of the peptide [32]. The hydrophobic counteranions interact electro-
statically with the positively charged arginine head groups, increasing
the hydrophobicity of the CPP, thus elevating the potential of the
peptide to interact with lipid bilayers and promoting the rapid and
direct translocation of the peptide through the membrane. It is
proposed that pyrenebutyrate acts like a translocation catalyst
accelerating the direct passage through the membrane without the
requirement for endocytosis, instead, the membrane potential is
suggested to be the driving force in this type of translocation [31].
Another recently published paper by Inomata et al. [33] indicates that
indeed arginine-rich peptides, in this case Tat peptide, deliver
covalently linked protein cargo effectively into the cytosol when
cells are pretreated with pyrenebutyrate, inferring to a process of
direct penetration. In addition, their data reveal that cytosol-delivered
proteins detach from the carrier CPP, yielding a homogeneous
dispersion of labeled proteins in the cytosol, where they are ready
to form speciﬁc protein–protein or protein–drug complexes.
The utilization of pyrenebutyrate as translocation accelerator has,
however, a considerable drawback in therapeutic (in vivo) application—
the presence of a medium or serum generates competition and thus
hampers the interaction of the arginine vectors with pyrenebutyrate,
limiting the use of pyrenebutyrate only to “ex vivo”-like approaches,
where isolated cells are treated with target proteins and later
incorporated back into the body [31].
In addition, the results of Guterstam et al. [34] give evidence that
the enhancement of translocation by the hydrophobic counteranion
pyrenebutyrate is limited only to arginine-rich peptides (i.e.,
oligoarginine, Tat peptide, etc.), whereas no improvement was
observed for more hydrophobic CPPs, i.e., TP10. It was hypothesized
that the high hydrophobicity of the peptide itself may preclude the
potential contribution of the hydrophobic counteranion, which is why
no additional effects were detected for TP10. Furthermore, they
discovered that when a larger cargo molecule, i.e., oligonucleotide
(ON), was attached to the highly cationic CPP, the uptake mechanism
switched to a much slower route, referring to the conversion from the
direct translocation to an endosomal internalization. The authors
suggested that since chloroquine, a lysosomotropic agent delaying the
lysosomal pathway for endosomes and facilitating potential endoso-
mal release, severely enhanced the successful delivery of nona-
arginine-ON complexes, the uptake mechanism clearly comprises an
additional endocytic route and is not exclusively limited to direct
penetration [34]. Nevertheless, Guterstam et al. [34] propose that
although cargo delivery with CPPs is achieved mainly by endocytosis,
pyrenebutyrate may also promote the translocation of CPP–cargo
complexes through the endosomal membranes, facilitating thus their
endosomal escape and subsequent cytosolic delivery, achieving,
therefore, the same desired goal.
Despite some unpredicted drawbacks, the pyrenebutyrate strategy
may offer valuable data for the advancement of the ﬁeld of direct
penetration of CPP–cargo complexes, and the ongoing pursuit for
serum/medium-insensitive counteranions indicates their potential in
effective CPP-mediated delivery.4. Which endosomal gate to choose?
To date, all known types of endocytosis have been reported to
participate in the cellular uptake of CPP–cargo complexes. However,
the contribution of each endosomal pathway to this process is rather
complicated to measure because inhibition of one route can
upregulate another [35] and markers used to visualize a particular
endosomal route can lack in speciﬁcity. Moreover, different cell types
and lines can vary intrinsically in the activity of different endosomal
pathways and in response to inhibitors [36], making the extrapolation
of obtained results more difﬁcult. For example, the ﬂuid phase uptake
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well as have varying extents [37].
In rather undifferentiated cultured cell lines that are mostly used
to analyze the uptake mechanisms of CPP–cargo complexes, most of
the endosomal pathways are functional, except phagocytosis. There-
fore, clathrin- and caveolin-mediated endocytosis, macropinocytosis
as well as ﬂuid phase uptake are usually tested if one aims to identify
the vesicular structures that contain CPP–cargo complexes. Although
clathrin-mediated endocytosis as one uptake route for CPP–cargo
complexes has been demonstrated several times [11,26,38], this
endosomal pathway is believed to be a rather incidental event in CPP-
mediated cargo delivery because binding of a speciﬁc ligand to the
receptor is considered to trigger the budding of the clathrin-coated
vesicle from the plasma membrane. We have demonstrated that
when complexes of biotinylated transportan and streptavidin were
applied to HeLa cells in combination with transferrin that enters cells
via the clathrin-mediated endocytosis, the iron transporter and the
peptide–protein construct were often found in the same vesicular
structures [11] (Fig. 1B). However, low overlap was detected when
these two moieties were applied onto cells at different time points.
This shows that at least a part of the detected colocalization could
result from the electrostatic interactions between the highly basic
complexes and the slightly acidic transferrin in the extracellular
environment, leading to the uptake of both protein molecules in the
same endosomes and thus to the overestimation of the ratio of
colocalization. The rather insigniﬁcant role of the clathrin-mediated
endocytosis in CPP-mediated delivery was supported also by the
analysis of Rab5-positive early endosomes in HeLa cells, in which
CPP–protein complexes were rarely detected [12]. Similarly to our
results, Fittipaldi et al. [39] found another marker of early endosomes,Fig. 1. Involvement of different endosmal pathways in the protein uptake by transportan. (A
(A) and transferrin (green) (B) in HeLa cells. (D) Overlap between TP–avidin complexes
endosomes; low colocalization between TP–avidin and TGN46 indicates the redirection of
green. Scale bar, 10 µm. (C) Involvement of caveolin-1-dependent endosomal pathway in TP-
caveolin-1 by RNA interference and subsequent FACS analysis. Uptake of TP-protein complex
represents relative ﬂuorescence units.early endosomal antigen 1 (EEA1), not to colocalize with the fusion
protein of Tat peptide and green ﬂuorescent protein (GFP). However,
in the uptake of PNA–CPP constructs, the clathrin-dependent route
has been shown to prevail [26,38]; therefore, the exploitation of an
unidentiﬁed receptor and the subsequent clathrin-dependent uptake
can still take place.
Another type of endocytosis that is extensively used by dendritic
cells and ﬁbroblasts—macropinocytosis—has also been reported to
play a signiﬁcant role in CPP-mediated uptake. The macropinocytic
vesicle forms as a result of plasmamembrane rufﬂing accompanied by
the extensive dynamics of the cortical actin and the activity of several
kinases or effector proteins like Pak1, Rac1, PI3K, and PKC, when
naming only a few. Specialized cell types exploit macropinocytosis for
the constitutive uptake of big volumes of extracellular ﬂuid, but
almost all cell types are capable of macropinocytosis if speciﬁcally
induced [40]. A number of reports showmacropinocytosis as themain
[10,41], or one of the major pathways [14,42] mediating the uptake of
CPP–cargo complexes, supporting the concept of CPP-induced
nonspeciﬁc endocytosis. We have found that protein delivered into
Bowes and HeLa cells by transportans often reside in large vesicular
structures that could be classiﬁed as macropinosomes by morphology
[11]. Still, if the uptake process of CPPs is the induced macropinocy-
tosis, one could ask what is the inducer triggering the membrane
rufﬂing and the subsequent engulfment of the peptide vector and
cargo. Because most CPPs are positively charged, their interaction
with negatively charged heparan sulfate proteoglycans (HSPG) on the
plasma membrane and the subsequent endocytosis was proposed
shortly after the introduction of CPPs [43]. After that, the necessity of
HSPGs in the uptake of CPPs and CPP–cargo complexes has been
corroborated repeatedly [25,27,44,45]. Still, there are some studies, B) A partial colocalization between TP–avidin complexes (red) with caveolin (green)
and trans-Golgi marker TGN46 in Cos7 cells revealing the localization of recycling
complexes from the recycling pathway. TP–avidin complexes—red, cellular markers—
mediated cargo delivery in HeLa cells was additionally conﬁrmed by down-regulation of
es in cells treated with Cav-1-speciﬁc (light gray) and control siRNA (dark gray). Y-axis
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arginine-rich peptides. For example, M918, a peptide originating from
the p14Arf protein, was shown to carry PNA more efﬁciently to
heparinase III-treated HeLa pLuc than control cells [46]. Corroborating
results were obtained with ﬂuorescently labeled M918 in HSPG-
deﬁcient CHO cells, where the uptake of peptide was only slightly
inhibited compared to a three-fold decrease in the internalization of
ﬂuorescent TP10 and penetratin [38]. Thus, if HSPG as the putative
trigger of macropinocytosis is not present, M918 is apparently still
able to induce its uptake into structures more prone to leakage or, the
peptide itself could possess higher leakage-inducing properties
independent of the nature of the endosome.
In parallel with the detection of transportan–protein complexes in
macropinosome-like endosomes a substantial amount of caveolin-
positive vesicles were observed to contain CPP–protein complexes [12]
(Figs. 1A and 2B). Moreover, the participation of caveolin-dependent
endocytosis in the uptake of CPP-protein complexes was further
conﬁrmed by the down-regulation of cellular caveolin-1 that led to a
40% decrease in the uptake of complexes [12] (Fig. 1C). Furthermore,
analogously, the caveolae have been demonstrated to mediate the
cellular uptake of the fusion protein of Tat peptide with GFP [29,39].
Both of these studies demonstrated a partial overlap of the fusion
protein with the cellular caveolin, but interestingly, more extensive
colocalization was detected with cholera toxin B subunit, which is
known to use glycolipid ganglioside M1 as the receptor [47]. Caveolae,
i.e., plasma membrane areas that contain the protein caveolin, are
classiﬁed as a subtype of plasma membrane raft microdomains.
Ganglioside M, on the other hand, is likely able to localize in the raft-
like membrane areas that do not necessarily need the presence of
caveolin. Flotillin-containing membrane domains are described as
another type of membrane rafts morphologically similar to caveolae,
and indeed, cholera toxin can be takenupby cells also via thosedomains
[48]. However, we were not able to detect CPP–protein complexes in
ﬂotillin-positive endosomes, although some very rare colocalization
was observed at the plasma membrane by electron microscopical
analysis. The negligible role of the ﬂotillin-containing plasma mem-
brane rafts in the protein delivery by transportans was further
corroboratedby thedown-regulation ofﬂotillin,whichhadno inﬂuence
on the protein uptake in HeLa cells [12]. These data infer that even if the
uptake of CPP–cargo complexes can be characterized as induced
endocytosis, the term “nonspeciﬁc” should be rather avoided becauseFig. 2. Internalization and intracellular trafﬁcking of CPP-protein complexes. First, CPP–p
interactions (A, TP–neutravidin), then, internalization of CPP–protein complexes inside ros
targeting and accumulation of the complexes into LAMP-2-positive lysosomes in the perinuc
some CPPs are observed inside vesicles with a discontinuous membrane (D, TP10–neutravid
pictures are a courtesy of Dr. Kärt Padari.the interaction with the plasma membrane takes place at certain areas
and some uptake pathways are clearly dominating.
One possibility to explain the involvement of several endosomal
pathways in the uptake of CPP–cargo complexes in parallel could be as
follows: the attachment of complexes to the plasma membrane
components (proteins, proteoglycans, or lipids) (Fig. 2A) leads to the
cholesterol- and actin-dependent recruitment of the plasma mem-
brane microdomains followed by the subsequent endosomal events,
active to various extents in different cell lines. This scenario
(analogous to the clustering of immunological synapses [49]) is
supported by the demonstration of the equally ubiquitous inhibiting
inﬂuence of actin depolymerization and/or cholesterol depletion on
the cellular uptake of CPPs and CPP–cargo complexes [6,10,39,50],
while the inﬂuence of the various endosomal inhibitors remains
mostly cell line-dependent and rarely reaches to the total arrest of the
uptake. The internalization of the CPP or CPP–cargo constructs into F-
actin- or cholesterol-depleted cells might not be totally excluded,
although, where instead of natural endocytic internalization mode(s),
other (and up to now poorly characterized) mechanism(s) can lead to
the nonendosomal uptake in conditions where actin cortex is absent
and ﬂuidity of plasma membrane is extensively changed. In addition,
however, the comprehensive amount of data showing the inhibition
of endosomal uptake of Tat-fusion protein in the absence of HSPGs
[10,39] or after the enzymatic digestion of plasmamembrane proteins
[51] suggest that a speciﬁc receptor at least for Tat cannot be totally
excluded.
5. The intracellular meshwork of endocytic pathways
As seen above, the internalization route(s) utilized by CPP–cargo
constructs are fairly well documented, but the data available are
ambiguous and often contradictory. The fate of the complexes after cell
entry, however, is far less investigated, and thus, very little information
exists on their intracellular trafﬁcking. Because endocytosis is conﬁrmed
to play a major part in the internalization of CPP–cargo complexes, it is
essential for future studies to dissect in detail the events happening after
endocytic capture at the plasma membrane.
Following budding from the cell membrane, the engulfed material
in endosomal vesicles is recently shown to be subject to rapid sorting
already before reaching the early endosomes [52,53]. Depending on,
i.e., the nature and even the concentration of the internalized materialrotein complexes associate with the plasma membrane components via electrostatic
ette-like caveolar structures occurs (B, Tat–neutravidin) and after longer incubations,
lear region is evident (C, TP10–neutravidin). Occasionally, especially with TP and TP10,
in) inferring to membrane disruption and leakage. Bar, 100 nm. All electron microscopy
2244 H. Räägel et al. / Biochimica et Biophysica Acta 1798 (2010) 2240–2248[54], it can be directed to different cellular destinations. In addition,
sorting in the early endosomes by a complex network of proteins and
effectors (i.e., Rab5, PtdIns(3)P-kinase, etc.) deﬁnes the intracellular
trafﬁcking of the internalized molecules [55]. For example, the
classical clathrin-mediated pathway recycles some of its contents
back to the plasma membrane, whereas most of the materials from
the clathrin-coated vesicles are targeted to late endosomes and
lysosomes for degradation [52,56]. Macropinosomes entrapping the
material internalized by ﬂuid-phase uptake from the extracellular
environment are also considered to target their contents to lysosomal
degradation [57]. EGF, a classical clathrin-mediated endocytosis
marker, as well as the commonly used ﬂuid phase marker dextran,
are after internalization indeed found in endosomes of varying pH
being trafﬁcked to low-pH vesicular structures in a time-dependent
manner [13], corroborating the data described above. Caveosomes
resulting from caveolin-dependent endocytosis, on the other hand,
are not necessarily subject to decrease in pH and subsequent
degradation [58,59]. For example, SV40 and the cholera toxin both
have been proven to (at least partially) utilize caveosomes to enter
cells and reach the Golgi apparatus or the endoplasmatic reticulum by
retrograde transport [60–62]; however, the proportion and relevance
of this kind of targeting in the intracellular trafﬁcking of CPP–cargo
complexes are not clear. In general, rather little is known about the
actual destiny of the contents of caveosomes. Nevertheless, because
caveosomes are reported to be involved in the uptake of CPP–cargo
complexes [12,29,39], it is especially important to ﬁgure out the
intracellular pathway and targeting of these medium-pH caveosomes,
where most of the complexes are hopefully still intact and bioactive.
So far, how the cellular signals deﬁne the sorting and trafﬁcking of
the endocytosed material is mostly unknown, but there are indica-
tions that the very ﬁrst steps of internalization might determine
where the endosomal contents are destined inside the cell [52,63].
Thus, the understanding about the internalization pathways chosen
by a particular CPP or CPP–cargo complex is essential. However, the
complexity and crossing of intracellular endocytic routes make it
difﬁcult to analyze.
6. Next sorting point—The recycling or the endolysosomal
pathway?
The abovementioned endocytic routes lead the engulfed material to
early endosomes that serve as a sorting and distribution station inside
the cell. From there, two main intracellular pathways begin—the
recycling and the lysosome-targeted route [64,65]. The classical view
of the recycling pathway depicts that the material in recycling
endosomes is targeted back to the plasma membrane [66], while the
end point of the endolysosomal route is at the degradative lysosome
[67,68]. The sorting in early endosomal compartment thus determines
the successive direction of the CPP–cargo complexes. We recently
demonstrated that the recycling pathway plays only a negligible role in
CPP-mediated protein delivery because only up to 10% of the
internalized complexeswere found residing in the recycling endosomes
[13] (Fig. 1D). Therefore, the majority of the complexes instead follow
the endolysosomal pathway during their intracellular trafﬁcking.
7. Trafﬁcking through the endolysosomal pathway to lysosomes
The endolysosomal pathway is comprised of a complex network of
vesicular structures, which protein composition (i.e., Rab proteins)
and acidity reﬂect their level of maturation. The material sorted from
the early endosomes towards the endolysosomal pathway follows the
step-by-step maturation process and is ﬁnally degraded in low pH
lysosomes. An elegant paper by Rink et al. [69] demonstrates that the
cargo assigned for degradation becomes highly enriched in progres-
sively fewer and larger endosomes through repetitive fusion events.
Such large endosomes are rapidly displaced from the early-endosomalnetwork in the cell center by replacement of Rab5 with Rab7,
declaring the maturation of the vesicle to a late endosome. The late
endosomes fuse with lysosomes forming a population of large acidic
vesicles with a dense network of internal membranes [70] and an
increased activity of degradative enzymes [71].
It is shown by many groups that most of the CPP–cargo complexes
are after longer incubations found in large acidic compartments
[11,25,72,73] (Fig. 2C), where the hydrolytic enzymes break down the
complexes. Indeed, our own data suggest that after internalization,
the CPP–cargo complexes are trapped in vesicles of varying pH, which
in time become larger and more acidic, containing an increased
amount of the complexes [13] (Fig. 3). The gradual trafﬁcking of the
complexes to the lysosomal compartments and the likelihood of
degradation by lysosomal enzymes there impairs the potential of CPPs
as effective transporters and would thus negatively impact the
delivery of the cargo molecule to the target site.
8. The origin of medium-pH vesicles
When analyzing the acidity of the complexes-containing vesicles,
we determined several different populations depending on their pH
and intravesicular concentration of the cargomolecule [13] (Fig. 3). As
described above, some of the CPP–cargo complexes-containing
vesicles were designated as lysosomes possessing both a low pH
and a strong signal of the complexes (Fig. 3, lower panel, green circle).
However, we also observed a population of vesicles with an increased
cargo concentration, yet with a relatively neutral pH level even after
longer incubation times (i.e., 12 hours) (Fig. 3, lower panel, blue
circle). We hypothesized that the complexes entering the cells via the
caveolin-mediated pathway could result in the formation of the
discovered nonacidic vesicles since caveolin-dependent internaliza-
tion mode has previously been conﬁrmed in CPP-mediated protein
delivery [12,39]. As also mentioned above, caveosomes, forming after
budding of caveolin-positive vesicles at the plasma membrane and
subsequently merging with the rosette-like intracellular struc-
ture [74], are able to maintain the near-neutral pH and avoid the
acidiﬁcation and consequent digestion of the complexes [60]. Several
publications have demonstrated that the successive routes originating
from the caveosomes are directed towards the Golgi apparatus and/or
the endoplasmatic reticulum (ER) [60,61,75]. However, we have not
yet observed the ER or the Golgi apparatus to be the designated
destination for CPP–cargo complexes, which could mean that the
aforementioned intracellular compartments may not be the only
targets for the endosomes derived from the caveolin-mediated
pathway. In addition, their long-lived presence in the cells could
also refer to some other type of sorting or trafﬁcking from the neutral-
pH structures.
Nevertheless, we cannot rule out the possibility that CPPs them-
selves may alter the pH of the vesicles and render their acidiﬁcation, no
matter what the origin of the vesicles or which pathwaywas chosen for
cell entry. Our experimental data suggest that at least some CPPs can
inhibit the drop of pH in the vesicles they reside in, giving thus the
perceptionof neutral pH inside the endosomes (H.R., unpublisheddata).
This indicates that some highly positively charged peptides could have
the capacity to slow down the drop of pH in at least a part of the
entrapping endosomes, observed as the generation of the nonacidic
vesicles.
9. Enhanced escape from the entrapping endosomes
As mentioned above, the translocated CPPs appear to be persistent
in vesicles, accumulating in the vicinity of the nucleus. Regrettably,
the endocytic entry of the CPP–cargo complexes leads to the
entrapment of the material inside endosomes, rendering them unable
to release the (therapeutic) cargo into the cytosol. When looking at
the problem this way, being trapped inside the lumen of the vesicles is
Fig. 3. CPP–protein complexes induce 3 distinct populations of vesicles depending on pH and intravesicular concentration of complexes. The gradual growth of the complexes-
containing vesicles from 1 h (A) and 4 h (B) to 12 h (C) of incubation is accompanied by the accumulation of complexes (red) to increasingly fewer, yet larger vesicles. Analysis of pH
of complexes-containing vesicles with LysoSensor revealed 3 different populations (pop) with distinct pH and concentration of complexes, which proportions shifted in time. Pop1
(red circle) encompasses the vesicles with varying pH and relatively low levels of CPP–protein complexes (probably early endosomes), pop2 (green circle) is formed by vesicles with
both low pH and intense concentration of CPP–protein complexes (probably late endosomes and lysosomes), pop3 (blue circle) is composed of vesicles with high intravesicular
concentration of complexes, but with a relatively neutral pH (possibly caveosomes or other neutral intracellular vesicular structures). Ch1—intensity of LysoSensor (increases with
the drop of pH), Ch2—intensity of CPP–protein complexes.
Figure is adapted from Räägel et al. 2009, Journal of Controlled Release.
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still remains—how can CPPs or CPP–cargo constructs cross the
membrane? Many reports available agree that the step of endosomal
escape is an inefﬁcient process and the rate limiting event in CPP-
mediated delivery today [10,76,77]. However, it is clear that such an
escape must occur (as seen in Fig. 2D) to allow the cargo to reach its
intracellular target(s) and exert its activity.
The events inside the endosomes that could enhance the escape of
the CPP–cargo complexes are still not deﬁned. Vendeville et al. [73]
have demonstrated and thus argue that the gradual drop of pH is
needed to trigger, for example the conformational changes, leading to
the membrane insertion and the subsequent translocation of Tat
protein, similar to what is observed for several bacterial toxins
[78,79]. Evidence also supports that Tat protein is able to insert into
model membranes upon acidiﬁcation of the vesicles exposing its
tryptophan residue during molecular reorganization upon the drop of
pH [80]. Unfortunately, the tryptophan moieties responsible for the
insertion into the membrane are not present in the commonly used
Tat-derived peptide. Nevertheless, Abes et al. [77] found that when
using artiﬁcial liposomes prepared from the lipid mixture mimicking
the composition of the late endosomes, the acidic pH of 5.5 induced a
far stronger leakage of the CPP–phosphorodiamidate morpholino
oligomer (PMO) conjugates out of the entrapping vesicles than at
neutral pH. Also, the inhibition of the release of Tat peptide from the
endosomes and the subsequent hindrance of cytoplasmic and nuclear
delivery of the vector was demonstrated upon an increase of
endosomal pH by NH4Cl [81] or chloroquine [82], providing evidence
that endosomal acidiﬁcation is a prerequisite for effective escape. In
addition, the N-terminal part of the inﬂuenza virus hemagglutinin
protein (HA), a well-characterized pH-sensitive fusogenic peptide
that destabilizes lipid membranes at low pH [83], has been efﬁciently
used to increase the endosomal escape of entrapped material. In astudy byWadia et al. [10], for example, the CPP–cargo conjugates with
an extra HA-epitope were more prominent escapers than complexes
without the tag, inferring to the necessary pH drop which facilitates
the conformational changes in the HA contributing to the insertion of
the conjugate into the lipid bilayer of the endosomal vesicle. However,
since HA-epitope needs the drop of pH to bring about its conforma-
tional changes and induce the escape of the construct, it is likely that
the construct including the HA-tag is more prominently able to escape
from all the entrapping endosomes, especially from the ones
possessing lower pH, producing a far stronger biological activity of
the cargo protein. Therefore, one cannot preclude the possibility that
HA-enhanced escape occurs differently than that generated by CPPs.
Yet, when the level of the wanted biological activity of the cargo
molecule is at stake, the HA strategy could be a useful “upgrade” in
CPP-mediated transport.
To the contrary of the above-mentioned necessary pH drop during
endosomal escape, several papers prove that inhibition of endosomal
acidiﬁcation (i.e., by lysosomotropic agents, like chloroquine) elevates
the level of bioactivity of the cargo molecule arising from the
increased interaction of the cargo with its intracellular target
molecule(s) [16,84]. It should thus imply that the long-lived neutral
complexes-containing vesicles formed during intracellular trafﬁcking
of the CPP–cargo complexes may play a crucial role in the escape of
the bioactive CPP–cargo constructs from the entrapping endosomes.
However, since chloroquine, for example, induces also swelling of the
endosomal vesicles, one may also presume that the altered vesicular
membrane tends to bemore leaky or destabilized and therefore easier
to penetrate, resulting in the enhanced cytosolic delivery seen by
functional delivery assays by many different groups [84–87]. Still, the
earlier studies performed by Potocky et al. [81] and Fischer et al. [82]
showing a decrease in the intracellular ﬂuorescence after treatment
with inhibitors of endosomal acidiﬁcation can also be reconsidered in
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delivered cargo due to the inhibition of endosomal acidiﬁcation can be
independent of or opposite to the ﬂuorescence signal from the
conjugate [16].
Whether CPPs induce the formation of bacterial-toxin-like pores in
the membrane of the vesicles or embed into the membrane without
destroying its integrity is also not clear. For example, the hydrophobic
nature of MPG (but probably also other CPPs with similar hydropho-
bic characteristics, i.e., Pep-1, Penetratin, etc.) facilitates the direct and
stable interaction between the CPP and themembrane lipids, inducing
the submersion of the carrier vector into the bilayer [88]. TP10,
another hydrophobic CPP, has been reported to give rise to membrane
perturbation and induce the leakage of calcein from large unilamellar
vesicles (LUVs) already at low concentrations, inferring to its ability to
bring about its translocation through the lipid bilayer [34]. These
results are also supported by Yandek et al. [89], showing the ability of
TP10 to create mass imbalance and subsequent membrane straining
in phospholipid vesicles, rendering the membrane permeable to the
encapsulated dye, which leaks out, concomitant with peptide
translocation. We have previously shown that accumulation and
clustering of CPPs at the plasma membrane interfere with the
regularity of its packing [90] and evoke plasma membrane repair
response [91]. In addition, it has been demonstrated that a high
concentration of the peptide may cause the vector to dive into the
membrane and facilitate the leakage through the lipid barrier [92,93].
Onemay speculate that similarmechanisms could be in use during the
endosomal escape of the CPP–cargo complexes, where the local
intravesicular concentration of CPP is eminently high. Thus, we
hypothesize that the large near-neutral pH vesicles containing a high
concentration of the CPP–cargo complexes observed during their
intracellular trafﬁcking [13] may provide a suitable environment forFig. 4. Endosomal entry and intracellular trafﬁcking of CPP–protein complexes. CPP–protein
the cell). The intracellular endocytic vesicles entrapping the complexes possess varying pH
arrow) or the endolysosomal pathway (majority of complexes, bold block arrow). Howev
(medium block arrow), where the microenvironment may provide favorable conditions for
endocytic pathways used in CPP-mediated protein uptake. Darkness of endocytic vesicle
endocytosis, Cav—caveolin-mediated endocytosis, F/CLIC—ﬂuid phase/clathrin-independen
—ﬂotillin-mediated endocytosis (plays no part in CPP–protein internalization).the complexes to stimulate membrane leakage (Fig. 2D) and the
subsequent entry to the cytosol giving rise to the biological effects
observed by numerous different groups [7,16,87]. Nonetheless, the
molar fraction of CPP–cargo complexes that is indeed able to escape
the vesicular compartment still remains elusive.
10. Conclusions and future prospects
A vast number of studies on CPPs and/or CPP–cargo complexes
have given a shred of insight to their uptake mechanisms and
intracellular trafﬁcking. However, the existing data are at times
controversial and may lead to ambivalent interpretation. The results
obtained with CPPs may not correlate precisely with the results with
CPP–cargo complexes or when comparing different cargoes with one
another, probably because of the different characteristics of the
compounds under investigation. In addition, some variation in CPP-
mediated delivery may occur due to the different properties of used
cell lines or tissues, i.e., the lipid composition or protein content of the
plasma membrane or even the rate of endocytosis, etc. Thus,
extrapolation of results to different experimental systems needs to
be done with caution. Nonetheless, it is clear by now that endocytosis
plays a crucial role in the internalization of CPPs and especially CPP–
cargo complexes leading to entrapment of the complexes inside
endocytic vesicles (see illustrative Fig. 4). However, at least a fraction
of the material does seem to be able to leak out from the endosomes
and exert biological activity at various cellular locations. This means
that the biologically active sites are not yet destroyed by the
degradative enzymes, hinting that the escape process takes place
before the deﬁnite acidiﬁcation of the vesicles. Thus, it could mean
that the medium-pH endosomes conﬁning a high concentration of
CPP or CPP–cargo complexes may provide a suitablemicroenvironmentcomplexes (red dots) may enter cells via different endocytic pathways (arrows outside
and may lead to either the recycling endosomes (minority of complexes, thin block
er, some of the complexes are found also inside vesicles with a relatively neutral pH
the complexes to leak out into the cytosol. Arrow thickness indicates the extent of the
s corresponds with their acidity. Macr—macropinocytosis, Clathr—clathrin-mediated
t carriers (involvement in CPP-mediated protein delivery has not yet been deﬁned), Flot
2247H. Räägel et al. / Biochimica et Biophysica Acta 1798 (2010) 2240–2248to produce leaky vesicles. Therefore, it is important for future studies to
focus on the origin of these nonacidic vesicles to better understand the
events behind the endosomal leakage and the productive CPP-mediated
delivery.
The ﬁeld of CPPs and CPP-mediated delivery has evolved
enormously during the past 15 years. Hopefully, the next 15 will
reveal answers and solutions for currently encountered questions and
problems, widening the positive perspectives of CPP-mediated cargo
delivery and its possible applications.
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